Stocks
Haemonetics Corporation (HAE) EBITDA margin US GAAP (year values) |
|||||||||
| FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 19.3% | 21.6% | 22.6% | 26.2% | 23.4% | 25.3% | ||
| Changes by years, y/y, % | -2pp | +2pp | +1pp | +4pp | -3pp | +2.0% | |||
Haemonetics Corporation. EBITDA margin, %
Haemonetics Corporation. EBITDA margin, changes, pp
Haemonetics Corporation (HAE) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q3 | FY2026Q4 | LTM ? | |||
| EBITDA margin, % | ? | 24.1% | 29.2% | 26.5% | 28.2% | 1.24% | 25.3% | |
| Changes by years, y/y, % | +4pp | +5pp | +1pp | +1pp | -23pp | |||
| Changes by quarters, q/q, % | -3pp | +5pp | -3pp | +2pp | -27pp | |||
